Pancreatic Cancer: Articles of Note @PharmaceuticalIntelligence.com
Curator: Aviva Lev-Ari, PhD, RN
Li -Fraumeni Syndrome and Pancreatic Cancer
Author: Marzan Khan, B.Sc.
https://pharmaceuticalintelligence.com/2016/12/14/li-fraumeni-syndrome-and-pancreatic-cancer/
Pancreatic cancer tumorigenesis is neither gradual nor follows the accepted mutation order – A Study of changes in DNA copy number and their associated rearrangements in tumour-enriched genomes: Mitotic errors, consistent with punctuated equilibrium as the principal evolutionary trajectory.
Reporter: Aviva Lev-Ari, PhD, RN
DISCUSSION – Genomics-driven personalized medicine for Pancreatic Cancer
Reporter: Aviva Lev-Ari, PhD, RN
COMBAT study: Combination of BL-8040 and KEYTRUDA® (pembrolizumab) for Pancreatic Cancer: Collaboration Agreement Merck, BioLineRx and MD Anderson Cancer Center
Reporter: Aviva Lev-Ari, PhD, RN
A New Potential Target for Pancreatic Cancer Treatment: Rapid Screening Technique finds Gene Defending Tumors from DNA Damage @M. D. Anderson Cancer Center
Reporter: Aviva Lev-Ari, PhD, RN
Oncolytic Virotherapy for Pancreatic Cancer: Overcoming Obstacles in Oncolytic Virus Delivery
Reporter: Aviva Lev-Ari, PhD, RN
Trovagene’s ctDNA Liquid Biopsy urine and blood tests to be used in Monitoring and Early Detection of Pancreatic Cancer
Reporters: David Orchard-Webb, PhD and Aviva Lev-Ari, PhD, RN
Hyaluronidase treatment of high HA pancreatic cancer increased progression-free survival
Author: David Orchard-Webb, PhD
Targeting paclitaxel to the pancreas with a biodegradable drug-eluting device
Author: David Orchard-Webb, PhD
Recent Research On SMAD4 In Pancreatic Cancer
Curator: David Orchard-Webb, PhD
https://pharmaceuticalintelligence.com/2016/06/27/recent-research-on-smad4-in-pancreatic-cancer/
Pancreatic Cancer Modeling using Retrograde Viral Vector Delivery and IN-Vivo CRISPR/Cas9-mediated Somatic Genome Editing
Curators: Larry H. Benstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Mutations in RAS genes
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/04/23/mutations-in-ras-genes/
TP53 tumor Drug Resistance Gene Target
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/12/27/p53-tumor-drug-resistance-mechanism-target/
Pancreatic Cancer Targeted Treatment?
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/05/18/pancreatic-cancer-targeted-treatment/
Aduro Biotech Phase II Pancreatic Cancer Trial CRS-207 plus cancer vaccine GVAX Fails
Reporter: Stephen J Williams, PhD
The “Guardian Of The Genome” p53 In Pancreatic Cancer
Curator: David Orchard-Webb, PhD
Targeting Epithelial To Mesenchymal Transition (EMT) As A Therapy Strategy For Pancreatic Cancer
Curator: David Orchard-Webb, PhD
Pancreatic Cancer at the Crossroads of Metabolism
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/10/13/pancreatic-cancer-at-the-crosroad-of-metabolism/
Using CRISPR to investigate pancreatic cancer
Reporter: Aviva Lev-Ari, PhD, RN
https://pharmaceuticalintelligence.com/2015/07/31/using-crispr-to-investigate-pancreatic-cancer/
Prostate Cancer Cells: Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition
Reporter-Curator: Stephen J. Williams, PhD
@Mayo Clinic: Inhibiting the gene, protein kinase D1 (PKD1), and its protein could stop spread of this form of Pancreatic Cancer
Reporter: Aviva Lev-Ari, PhD, RN
Locally Advanced Pancreatic Cancer: Efficacy of FOLFIRINOX
Reporter: Aviva Lev-Ari, PhD, RN
Consortium of European Research Institutions and Private Partners will develop a microfluidics-based lab-on-a-chip device to identify Pancreatic Cancer Circulating Tumor Cells (CTC) in blood
Reporter: Aviva Lev-Ari, PhD, RN
What`s new in pancreatic cancer research and treatment?
Reporter: Aviva Lev-Ari, PhD, RN
Pancreatic Cancer: Genetics, Genomics and Immunotherapy
Author: Tilda Barliya, PhD
https://pharmaceuticalintelligence.com/2013/04/11/update-on-pancreatic-cancer/
Targeting the Wnt Pathway
Writer and Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/04/10/targeting-the-wnt-pathway-7-11/
Gene Amplification and Activation of the Hedgehog Pathway
Curator: Larry H Bernstein, MD, FCAP
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aptubman
Arav Gandhi
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22